AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Continente #
AS - Asia 6.209
NA - Nord America 2.108
EU - Europa 923
SA - Sud America 179
AF - Africa 39
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.468
Nazione #
SG - Singapore 5.031
US - Stati Uniti d'America 2.030
CN - Cina 644
IT - Italia 376
HK - Hong Kong 270
GB - Regno Unito 154
BR - Brasile 140
FR - Francia 106
DE - Germania 85
VN - Vietnam 83
FI - Finlandia 49
NL - Olanda 44
IN - India 39
MX - Messico 35
CA - Canada 33
TR - Turchia 25
BD - Bangladesh 17
ES - Italia 16
ID - Indonesia 16
PL - Polonia 16
AR - Argentina 14
ZA - Sudafrica 13
JP - Giappone 12
RU - Federazione Russa 11
UA - Ucraina 11
CZ - Repubblica Ceca 10
LT - Lituania 10
PK - Pakistan 10
AU - Australia 8
EC - Ecuador 8
IQ - Iraq 8
SA - Arabia Saudita 8
AT - Austria 6
MY - Malesia 6
PH - Filippine 6
JO - Giordania 5
PE - Perù 5
SE - Svezia 5
MA - Marocco 4
TN - Tunisia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
KH - Cambogia 3
MD - Moldavia 3
OM - Oman 3
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HT - Haiti 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
PY - Paraguay 2
TL - Timor Orientale 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
RW - Ruanda 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
Totale 9.465
Città #
San Jose 642
Singapore 444
Ashburn 410
Dallas 267
Hong Kong 265
Rome 257
Hefei 206
Beijing 182
London 123
Boardman 116
Lauterbourg 85
Shanghai 73
Council Bluffs 59
Munich 56
Santa Clara 40
West Jordan 40
Los Angeles 39
Ho Chi Minh City 36
Amsterdam 34
Turku 26
Helsinki 23
San Francisco 23
Washington 23
New York 21
São Paulo 21
Mexico City 20
Sona 20
Seattle 19
Bari 15
Warsaw 15
Ankara 14
Toronto 14
Pune 12
Atlanta 10
Brno 10
Brooklyn 10
Hanoi 10
Tokyo 10
Changsha 9
Orem 9
Boston 8
Chennai 8
Manchester 8
Charlotte 7
Milan 6
Rio de Janeiro 6
Chengdu 5
Chicago 5
Frankfurt am Main 5
Haiphong 5
Johannesburg 5
Lahore 5
Montreal 5
Paris 5
Phoenix 5
Amman 4
Belo Horizonte 4
Brasília 4
Da Nang 4
Duino-Aurisina 4
Haikou 4
Naples 4
Noicattaro 4
Nuremberg 4
Philadelphia 4
Ribeirão Preto 4
State College 4
Baghdad 3
Brest 3
Casablanca 3
Denver 3
Guangzhou 3
Guayaquil 3
Guiyang 3
Hải Dương 3
Kuala Lumpur 3
Lima 3
Manila 3
Mumbai 3
Muscat 3
New Delhi 3
Ninh Bình 3
Pasadena 3
Phnom Penh 3
Redmond 3
Secaucus 3
Stockholm 3
Sydney 3
Tashkent 3
The Dalles 3
Vienna 3
Vilnius 3
Arcore 2
Atibaia 2
Balikpapan 2
Bandung 2
Basra 2
Cairo 2
Calgary 2
Campoformido 2
Totale 3.935
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 245
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 240
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 229
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 227
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 225
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 223
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 222
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 218
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 213
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 208
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 207
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 205
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 200
Leptin in immuno-rheumatological diseases 190
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 139
Diabetes in chronic liver disease: from old concepts to new evidence 133
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 131
GH-resistance in different stages of chronic liver disease 127
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 125
Enhanced portal flow velocity and volume following Iloprost treatment 124
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 123
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 123
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 123
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 122
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 119
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 117
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 116
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 116
Radiofrequency ablation of hepatic tissue: a new experimental animal model 115
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 114
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 113
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 112
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 112
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 111
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 108
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 108
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 106
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 102
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 101
Cannabinoids in Autoimmune and Rheumatic Diseases 101
Leptin in autoimmune mechanisms of systemic rheumatic diseases 101
ANA testing in ‘real life’ 99
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 97
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 94
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 91
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 88
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 84
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 81
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 73
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 69
TNF-alpha and growth hormone resistance in patients with chronic liver disease 66
Pain and Frailty in Hospitalized Older Adults 66
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 61
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 60
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 59
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 59
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 57
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 57
Phase angle could be a marker of microvascular damage in systemic sclerosis 57
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 56
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 56
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 56
The involvement of T regulatory lymphocytes in a cohort of lupus nephritis patients: a pilot study 54
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 54
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 54
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 53
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 51
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 51
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 50
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 50
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 50
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 50
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 49
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 49
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 49
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 48
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 47
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 47
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 47
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 46
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 46
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 45
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 44
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 44
Matters of the heart: The case of TNF-alpha targeting drugs 43
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 43
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 43
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 42
Surgical complications after resection of adrenal carcinoma 42
Utility of ultrasound in the diagnosis of chronic worsened gout 41
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 41
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 41
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 41
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 40
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 40
Serum level of endostatin and digital ulcers in systemic sclerosis patients 39
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 38
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 37
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 37
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 37
Totale 9.403
Categoria #
all - tutte 50.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20255.517 58 41 143 42 94 123 40 25 265 355 1.874 2.457
2025/20263.308 324 193 331 267 158 209 1.017 207 239 303 60 0
Totale 9.534